IL3RA and CD4+/CD56+ hematodermic neoplasm: CD123, the interleukin-3 receptor alpha chain (IL-3Rα), is aberrantly expressed in AML and other hematologic malignancies, such as blastic plasmacytoid dendritic cell neoplasm (BPDCN) and ALL10,11.